The Treatment of HIV-Associated Nephropathy

Advances in Chronic Kidney Disease

Volumn 17, Issue 1, 2010, Pages 59-71

  Kalayjian, Robert C ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Antiretroviral therapy; CKD; HIV associated nephropathy; Prednisone

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT; DIDANOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; PREDNISONE; STAVUDINE; TENOFOVIR DISOPROXIL; ZIDOVUDINE;

CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; PRIORITY JOURNAL; REVIEW;

ADRENAL CORTEX HORMONES; AIDS-ASSOCIATED NEPHROPATHY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-RETROVIRAL AGENTS; HUMANS; KIDNEY;

EID: 71249109909     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2009.08.013     Document Type: Review

References (45)

1. Hammer S.M., Eron Jr. J.J., Reiss P., et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 300 (2008) 555-570
2. Kimmel P.L., Mishkin G.J., and Umana W.O. Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 28 (1996) 202-208
3. Szczech L.A., Edwards L.J., Sanders L.L., et al. Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol 57 (2002) 336-341
4. Lucas G.M., Eustace J.A., Sozio S., et al. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS 18 (2004) 541-546
5. Szczech L.A., Gupta S.K., Habash R., et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66 (2004) 1145-1152
6. Smith M.C., Austen J.L., Carey J.T., et al. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med 101 (1996) 41-48
7. Laradi A., Mallet A., Beaufils H., et al. HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Nephrologiques d'Ile de France. J Am Soc Nephrol 9 (1998) 2327-2335
8. Eustace J.A., Nuermberger E., Choi M., et al. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int 58 (2000) 1253-1260
9. Wei A., Burns G.C., Williams B.A., et al. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int 64 (2003) 1462-1471
10. Krawczyk C.S., Holmberg S.D., Moorman A.C., et al. Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS 18 (2004) 2171-2178
11. El-Sadr W.M., Lundgren J.D., Neaton J.D., et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355 (2006) 2283-2296
12. Kalayjian R.C., Franceschini N., Gupta S.K., et al. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 22 (2008) 481-487
13. Peters P.J., Moore D.M., Mermin J., et al. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int 74 (2008) 925-929
14. Reid A., Stohr W., Walker A.S., et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis 46 (2008) 1271-1281
15. Longenecker C.T., Scherzer R., Bacchetti P., et al. HIV viremia and changes in kidney function. AIDS 23 (2009) 1089-1096
16. Beversluis D, Reynolds S, Kityo C, et al: Greater Renal Function Preservation Is Associated with Continuous vs Intermittent ART [Abstract 742]. In: Programs and Abstracts of the 16th Conference on Retroviruses and Opportunistic Infections (Montreal, Quebec) 2009. Available at: http://www.retroconference.org. Accessed February 22, 2009
17. Crane H.M., Kestenbaum B., Harrington R.D., et al. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir. AIDS 21 (2007) 1431-1439
18. Mulenga L.B., Kruse G., Lakhi S., et al. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS 22 (2008) 1821-1827
19. Post F.A., Campbell L.J., Hamzah L., et al. Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis 46 (2008) 1282-1289
20. Han T.M., Naicker S., Ramdial P.K., et al. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 69 (2006) 2243-2250
21. Nochy D., Glotz D., Dosquet P., et al. Renal disease associated with HIV infection: A multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 8 (1993) 11-19
22. Connolly J.O., Weston C.E., and Hendry B.M. HIV-associated renal disease in London hospitals. QJM 88 (1995) 627-634
23. Winston J.A., Klotman M.E., and Klotman P.E. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 55 (1999) 1036-1040
24. Cohen S.D., and Kimmel P.L. Immune complex renal disease and human immunodeficiency virus infection. Semin Nephrol 28 (2008) 535-544
25. Berliner A.R., Fine D.M., Lucas G.M., et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 28 (2008) 478-486
26. Lucas G.M., Lau B., Atta M.G., et al. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: A tale of two races. J Infect Dis 197 (2008) 1548-1557
27. Briggs W.A., Tanawattanacharoen S., Choi M.J., et al. Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 28 (1996) 618-621
28. Navarrete J.E., and Pastan S.O. Effect of highly active antiretroviral treatment and prednisone in biopsy-proven HIV-associated nephropathy. J Am Soc Nephrol 11 (2000) A0504
29. Glesby M.J., Hoover D.R., and Vaamonde C.M. Osteonecrosis in patients infected with human immunodeficiency virus: A case-control study. J Infect Dis 184 (2001) 519-523
30. Miller K.D., Masur H., Jones E.C., et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 137 (2002) 17-25
31. Wali R.K., Drachenberg C.I., Papadimitriou J.C., et al. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 352 (1998) 783-784
32. Dellow E., Unwin R., Miller R., et al. Protease inhibitor therapy for HIV infection: the effect on HIV-associated nephrotic syndrome. Nephrol Dial Transplant 14 (1999) 744-747
33. Winston J.A., Bruggeman L.A., Ross M.D., et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344 (2001) 1979-1984
34. Betjes M.G., and Verhagen D.W. Stable improvement of renal function after initiation of highly active anti-retroviral therapy in patients with HIV-1-associated nephropathy. Nephrol Dial Transplant 17 (2002) 1836-1839
35. Mocroft A., Wyatt C., Szczech L., et al. Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS 23 (2009) 71-82
36. Gupta S.K., Smurzynski M., Franceschini N., et al. The effects of HIV-1 viral suppression and non-viral factors on quantitative proteinuria in the HAART era. Antivir Ther 14 (2009) 543-549
37. Gupta S.K., Parker R.A., Robbins G.K., et al. The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: Results from a randomized trial. Nephrol Dial Transplant 20 (2005) 2237-2242
38. Rodriguez R.A., Mendelson M., O'Hare A.M., et al. Determinants of survival among HIV-infected chronic dialysis patients. J Am Soc Nephrol 14 (2003) 1307-1313
39. Szczech L.A., Kalayjian R., Rodriguez R., et al. The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis. Kidney Int 63 (2003) 2295-2301
40. Izzedine H., Launay-Vacher V., and Deray G. Inadequacy of antiretroviral drugs dosage adjustment in HIV patients receiving dialysis. Kidney Int 64 (2003) 2324
41. Choi A.I., Rodriguez R.A., Bacchetti P., et al. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis 45 (2007) 1633-1639
42. Tourret J., Tostivint I., Tezenas Du Montcel S., et al. Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis. Clin Infect Dis 45 (2007) 779-784
43. Gupta S.K., Eustace J.A., Winston J.A., et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40 (2005) 1559-1585
44. Winston J., Deray G., Hawkins T., et al. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis 47 (2008) 1449-1457
45. Cohen A.H., Sun N.C., Shapshak P., et al. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 2 (1989) 125-128